Literature DB >> 31865786

High Blood Pressure and Cardiovascular Disease.

Flávio D Fuchs1, Paul K Whelton2.   

Abstract

Fragmented investigation has masked the overall picture for causes of cardiovascular disease (CVD). Among the risk factors for CVD, high blood pressure (BP) is associated with the strongest evidence for causation and it has a high prevalence of exposure. Biologically, normal levels of BP are considerably lower than what has typically been characterized as normal in research and clinical practice. We propose that CVD is primarily caused by a right-sided shift in the population distribution of BP. Our view that BP is the predominant risk factor for CVD is based on conceptual postulates that have been tested in observational investigations and clinical trials. Large cohort studies have demonstrated that high BP is an important risk factor for heart failure, atrial fibrillation, chronic kidney disease, heart valve diseases, aortic syndromes, and dementia, in addition to coronary heart disease and stroke. In multivariate modeling, the presumed attributable risk of high BP for stroke and coronary heart disease has increased steadily with progressive use of lower values for normal BP. Meta-analysis of BP-lowering randomized controlled trials has demonstrated a benefit which is almost identical to that predicted from BP risk relationships in cohort studies. Prevention of age-related increases in BP would, in large part, reduce the vascular consequences usually attributed to aging, and together with intensive treatment of established hypertension would eliminate a large proportion of the population burden of BP-related CVD.

Entities:  

Mesh:

Year:  2019        PMID: 31865786     DOI: 10.1161/HYPERTENSIONAHA.119.14240

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  120 in total

1.  Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial.

Authors:  Flávio D Fuchs; Luiz C N Scala; José F Vilela-Martin; Paul K Whelton; Carlos E Poli-de-Figueiredo; Ricardo Pereira E Silva; Miguel Gus; Luiz A Bortolotto; Fernanda M Consolim-Colombo; Rosane P Schlatter; José E Cesarino; Iran Castro; José A Figueiredo Neto; Hilton Chaves; André A Steffens; João G Alves; Andréa A Brandão; Marcos R de Sousa; Paulo C Jardim; Leila B Moreira; Roberto S Franco; Marco M Gomes; Abrahão Afiune Neto; Felipe C Fuchs; Dario C Sobral Filho; Antônio C Nóbrega; Fernando Nobre; Otávio Berwanger; Sandra C Fuchs
Journal:  Acta Diabetol       Date:  2020-10-13       Impact factor: 4.280

2.  A new mechanism for the sex differences in angiotensin II-induced hypertension: the role of macula densa NOS1β-mediated tubuloglomerular feedback.

Authors:  Jie Zhang; Larry Qu; Jin Wei; Shan Jiang; Lan Xu; Lei Wang; Feng Cheng; Kun Jiang; Jacentha Buggs; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-12

Review 3.  High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It.

Authors:  Taweesak Wannachalee; Leedor Lieberman; Adina F Turcu
Journal:  Curr Hypertens Rep       Date:  2022-02-14       Impact factor: 5.369

Review 4.  Application of omics in hypertension and resistant hypertension.

Authors:  Jiuqi Guo; Xiaofan Guo; Yingxian Sun; Zhao Li; Pengyu Jia
Journal:  Hypertens Res       Date:  2022-03-09       Impact factor: 3.872

Review 5.  Update on Management of Cardiovascular Diseases in Women.

Authors:  Fabiana Lucà; Maurizio Giuseppe Abrignani; Iris Parrini; Stefania Angela Di Fusco; Simona Giubilato; Carmelo Massimiliano Rao; Laura Piccioni; Laura Cipolletta; Bruno Passaretti; Francesco Giallauria; Angelo Leone; Giuseppina Maura Francese; Carmine Riccio; Sandro Gelsomino; Furio Colivicchi; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

6.  Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control.

Authors:  Daniel T Lackland; Virginia J Howard; Mary Cushman; Suzanne Oparil; Brett Kissela; Monika M Safford; Dawn O Kleindorfer; Leslie A McClure; George Howard
Journal:  Circulation       Date:  2020-10-05       Impact factor: 29.690

Review 7.  Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation.

Authors:  Jurgen A H R Claassen; Dick H J Thijssen; Ronney B Panerai; Frank M Faraci
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 37.312

8.  Relationship of Cardiac Autonomic Modulation with Cardiovascular Parameters in Adults, According to Body Mass Index and Physical Activity.

Authors:  William R Tebar; Raphael M Ritti-Dias; Jorge Mota; Bruna T C Saraiva; Tatiana M Damato; Leandro D Delfino; Breno Q Farah; Luiz Carlos M Vanderlei; Diego G D Christofaro
Journal:  J Cardiovasc Transl Res       Date:  2021-01-22       Impact factor: 4.132

9.  Characterization of ACE Inhibitory Peptides Prepared from Pyropia pseudolinearis Protein.

Authors:  Yuya Kumagai; Keigo Toji; Satoshi Katsukura; Rie Morikawa; Toshiki Uji; Hajime Yasui; Takeshi Shimizu; Hideki Kishimura
Journal:  Mar Drugs       Date:  2021-04-01       Impact factor: 5.118

Review 10.  The effects of chromium supplementation on blood pressure: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Mahtab Ghanbari; Mohammad Reza Amini; Kurosh Djafarian; Sakineh Shab-Bidar
Journal:  Eur J Clin Nutr       Date:  2021-07-23       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.